Skip to main content
. 2019 Jun 14;11(6):1338. doi: 10.3390/nu11061338

Table 1.

Patients’ characteristics.

Total
(n = 117)
Control Group
(n = 89)
POI Group
(n = 28)
p-Value
(Control vs. POI)
Gender (Men/Women) 88/29 68/21 20/8 0.595
Age (years) 64.0 ± 7.9 63.7 ± 7.5 65.0 ± 9.2 0.435
Height (cm) 163.4 ± 7.8 164.0 ± 7.5 161.5 ± 8.6 0.137
Weight (kg) 56.0 ± 8.9 56.0 ± 9.4 56.0 ± 7.5 1.000
BMI (kg/m2) 20.9 ± 2.7 20.8 ± 2.7 21.5 ± 2.7 0.203
UBW (kg) 60.2 ± 10.0 59.9 ± 9.5 61.1 ± 11.3 0.567
Preoperative morbidities
Mastication disorder 10 (8.5%) 7 (7.9%) 3 (10.7%) 0.638
Dysphagia 10 (8.5%) 9 (10.1%) 1 (3.6%) 0.280
Obstruction 42 (35.9%) 33 (37.1%) 9 (32.1%) 0.635
Glucose intolerance 30 (20.4) 23 (25.8%) 7 (25.0%) 0.929
Hypertension 32 (27.4%) 24 (27.0%) 8 (28.6%) 0.868
Dyslipidemia 8 (6.8%) 5 (5.6%) 3 (10.7%) 0.351
Tumor stage
(0/IA/IB/IIA/IIB/IIIA/IIIB/IV)
13/24/9/12/17/24/0/18 9/17/6/11/13/21/0/12 4/7/3/1/4/3/0/6 0.502
Operative procedure
(VATS/Open esophagectomy)
76/41 56/33 20/8 0.411
Esophageal reconstruction
(Gastric conduit/Jejunal graft)
110/7 84/5 26/2 0.767
Postoperative complications 77 (65.8%) 51 (57.3%) 26 (92.9%) <0.001
Postoperative morbidity 61 (52.1%) 39 (43.8%) 22 (78.6%) 0.001
Postoperative meal start (POD) 13.9 ± 13.6 10.1 ± 3.9 26.1 ± 23.7 0.002
Postoperative meal interruption 61 (52.1%) 39 (43.8%) 22 (78.6%) 0.001
Neoadjuvant therapy 60 (51.3%) 48 (53.9%) 12 (42.9%) 0.306
Postoperative hospital stay (days) 36.3 ± 26.3 26.7 ± 8.3 66.9 ± 38.4 <0.001
Postoperative chemotherapy within 1 year postoperatively * 55 (47.0%) 43 (48.3%) 11 (39.3%) 0.403
Recurrence within 1 year postoperatively * 37 (31.6%) 26 (29.2%) 10 (35.7%) 0.516
Postoperative mean survival time (years) 4.5 ± 2.3 4.7 ± 2.2 3.5 ± 2.4 0.016

Data are expressed as the mean ± standard deviation or as the number of patients. Imputed data (*) are expressed as the mean ± standard error or as number of patients. Differences among two groups were analyzed using the unpaired t-test and chi-square test. BMI, body mass index; UBW, usual body weight; VATS, video-assisted thoracoscopic esophagectomy.